Diabetes Mellitus. Idiopathic peripheral autonomic neuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are more than or equal to 18 years old Patients who have been diagnosed with diabetes for 10 years and more Patients who have Diabetic Peripheral Neuropathy (DPN) of more than 5 on Toronto Clinical neuropathy score (TCNS) Patients with Type-1 and Type-2 Diabetes Mellitus
Exclusion criteria
Exclusion criteria: Patients with score of 5 and less than in TCNS scale Patients who have Chemotherapy-Induced Peripheral Neuropathy Patients with foot gangrene Patients with amputated right or left foot Patients who refused to participate in the study Patients with paralysis, partly or entirely unable to move the affected parts of the body patients with osteoarthritis and osteomyelitis, rheumatoid arthritis Patient with certain viral or bacterial infections, including Lyme disease, shingles, Epstein-Barr virus, hepatitis B and C, leprosy, Diphtheria, and HIV) Patients who are receiving any physiotherapy intervention Patients with inherited disorders, such as Charcot-Marie-Tooth disease are hereditary types of neuropathy; Patients with autoimmune diseases, include lupus, Guillain-Barre syndrome, demyelinating polyneuropathy and vasculitis Patients with bone marrow disorders, These include Multiple myeloma, lymphoma and amyloidosis Patients with other diseases, include kidney and liver disease, connective tissue disorders and hypothyroidism)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome variable is the level of Diabetic Peripheral Neuropathy that can be changed based on foot bathing, foot massage, and ROM exercises. Timepoint: Before intervention and two weeks after intervention. Method of measurement: The Toronto Clinical Neuropathy Score will be used to assess the level of DPN. | — |
Countries
Iraq
Contacts
University of Kerbala